Effect of Alpha-Fetoprotein on Differentiation of Myeloid Supressor Cells.
alpha-fetoprotein (AFP)
immune tolerance
myeloid-derived suppressor cells (MDSC)
pregnancy
Journal
Doklady. Biochemistry and biophysics
ISSN: 1608-3091
Titre abrégé: Dokl Biochem Biophys
Pays: United States
ID NLM: 101126895
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
received:
30
04
2021
accepted:
07
09
2021
revised:
06
09
2021
entrez:
30
12
2021
pubmed:
31
12
2021
medline:
12
2
2022
Statut:
ppublish
Résumé
The effect of recombinant alpha-fetoprotein (AFP) on human myeloid suppressor cell (MDSC) differentiation was studied in vitro in the presence of cytokines IL-6 (10 ng/mL) and GM-CSF (10 ng/mL). It was found that AFP at concentrations of 50 and 100 IU/mL increased the number of MDSC (CD33
Identifiants
pubmed: 34966967
doi: 10.1134/S1607672921060077
pii: 10.1134/S1607672921060077
doi:
Substances chimiques
HLA-DR Antigens
0
Recombinant Proteins
0
alpha-Fetoproteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
434-437Informations de copyright
© 2021. Pleiades Publishing, Ltd.
Références
Terentiev, A.A. and Moldogazieva, N.T., Alpha-fetoprotein: a renaissance, Tumor Biol., 2013, vol. 34, pp. 2075–2091.
doi: 10.1007/s13277-013-0904-y
Schumacher, A., Costa, S.D., and Zenclussen, A.C., Endocrine factors modulating immune responses in pregnancy, Front. Immunol., 2014.
Pak, V.N., Alpha-Fetoprotein and Its Receptor in Fixing the Cancer Brakes, Cambridge Scholars Publ., 2021.
Gabrilovich, D.I. and Nagaraj, S., Myeloid-derived suppressor cells as regulators of the immune system, Nat. Rev. Immunol., 2009, no. 9, pp. 162–174.
Ostrand-Rosenberg, S. and Sinha, P., Myeloid derived suppressor cells: linking inflammation and cancer, J. Immunol., 2009, vol. 182, no. 8, pp. 4499–4506.
doi: 10.4049/jimmunol.0802740
Veglia, F., Sanseviero, E., and Gabrilovich, D.I., Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity, Nat. Rev. Immunol., 2021 (in press).
Kostlin, N., Kugel, H., Spring, B., Leiber, A., Marme, A., Henes, M., Rieber, N., Hartl, D., Poets, C.F., and Gille, C., Granulocytic myeloid derived suppressor cells expand in human pregnancy and modulate T-cell responses, Eur. J. Immunol., 2014, vol. 44, no. 9, pp. 2582–2591.
doi: 10.1002/eji.201344200
Belyaev, N.N., Abdolla, N., Perfilyeva, Y.V., Ostapchuk, Y.O., Krasnoshtanov, V.K., Kali, A., and Tleulieva, R., Daunorubicin conjugated with alpha-fetoprotein selectively eliminates myeloid-derived suppressor cells (MDSCs) and inhibits experimental tumor growth, Cancer Immunol. Immunother., 2018, vol. 67, no. 1, pp. 101–111.
doi: 10.1007/s00262-017-2067-y
Lechner, M.G., Liebertz, D.J., and Epstein, A.L., Characterization of cytokine-induced myeloid derived suppressor cells from normal human peripheral blood mononuclear cells, J. Immunol., 2010, vol. 185, no. 4, pp. 2273–84.
doi: 10.4049/jimmunol.1000901
Gagnon, A., Wilson, R.D., Audibert, F., Allen, V.M., Blight, C., Brock, J.A., Desilets, V.A., Johnson, J.A., Langlois, S., Summers, A., and Wyatt, P., Obstetrical complications associated with abnormal maternal serum markers analytes, J. Obstet. Gynaecol. Can., 2008, vol. 30, pp. 918–932.
doi: 10.1016/S1701-2163(16)32973-5
Kostlin, N., Hofstadter, K., Ostermeir, A.L., Spring, B., Leiber, A., Haen, S., Abele, H., Bauer, P., Pollheimer, J., Hartl, D., Poets, C.F., and Gille, C., Granulocytic myeloid-derived suppressor cells accumulate in human placenta and polarize toward a Th2 phenotype, J. Immunol., 2016, vol. 196, no. 3, pp. 1132–1145.
doi: 10.4049/jimmunol.1500340
Gonzalez-Bugatto, F., Foncubierta, E., Bailen, M., de L., Illanes, S., Hervias-Vivancos, B., and Bartha, J.L., Maternal and fetal serum transformed alpha-fetoprotein levels in normal pregnancy, J. Obstet. Gynaecol. Res., 2009, vol. 35, no. 2, pp. 271–276.
doi: 10.1111/j.1447-0756.2008.00931.x
Pak, V.N., Selective targeting of myeloid-derived suppressor cells in cancer patients through AFP-binding receptors, Future Sci. OA, 2018, vol. 5, no. 1, p. FSO321. https://doi.org/10.4155/fsoa-2018-0029
doi: 10.4155/fsoa-2018-0029
pubmed: 30652015
pmcid: 6331696